Publicaciones destacadas

• Jueves, 10 de abril de 2025

  Monreal E, Fernández JI, Álvarez R, Sainz de la Maza S,..., Zamora J, Rodero A, Espiño M,..., Rodríguez F, Chico JL, Sainz R, Masjuan J, Costa L, Villar LM. Serum biomarkers at disease onset for personalized therapy in multiple sclerosis

  Brain. 2024

  10.1093/brain/awae260

• Martes, 1 de abril de 2025

  López M, de Pablo R, de Dios NP, García S, Sáez S, de la Fuente JS, Fortún J, Cuesta MCS. The adverse impact of cytomegalovirus infection on intensive care units outcomes in critically ill COVID-19 patients: a single-center prospective observational study

  Infection. 2025

  10.1007/s15010-025-02499-8

• Martes, 18 de marzo de 2025

  Subiela JD,..., Gomez Dos Santos V, Jiménez MÁ, Burgos FJ. Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics

  Eur Urol Oncol. 2024

  10.1016/j.euo.2024.01.017

• Miércoles, 12 de marzo de 2025

  Sayer AA, Cooper R, Arai H, Cawthon PM, Ntsama MJ, Fielding RA, Grounds MD, Witham MD, Cruz-Jentoft AJ. Sarcopenia

  Nat Rev Dis Primers . 2024

  10.1038/s41572-024-00550-w